High HAMA K2 EDTA Plasma
$20.99
$35.05
Product Description 4.9/5 - (21 votes) High HAMA K2 EDTA Plasma Catalog number: S2010006P7 Lot number: Batch Dependent Expiration date: Batch Dependent Volume: 1 mL Appearance: Yellow orange Matrix: Human K2 EDTA Plasma Storage: At -20°C or lower. Avoid repeated freeze-thaw cycles. Aliquot as needed. Keywords HAMA sample, Human Anti-Mouse Antibodies plasma, High HAMA K2 EDTA plasma, HAMA K2-EDTA plasma, HAMA dipotassium EDTA plasma About HAMA Immunoassays rely heavily on mouse antibodies for the detection of various analytes. The accuracy of these assays can, however, suffer when samples contain human anti-mouse antibodies (HAMA). Indeed, HAMA are often associated with inaccurate results because they can bind to both capture and detection antibodies and can generate non-specific signals. This so-called HAMA effect is major interference issue. Assessing the tolerance of an immunoassay to HAMA and mitigating it is very important important during research and development. Products Related to High HAMA K2 EDTA Plasma: High HAMA K3 EDTA Plasma References: 1: Mukherjee S, Ayanambakkam A, Ibrahimi S, Schmidt S, Charkrabarty JH, Khawandanah M. Ibritumomab tiuxetan (Zevalin) and elevated serum human anti-murine antibody (HAMA) Hematol Oncol Stem Cell Ther. 2018 Sep;11(3):187-188. 2: Klee GG. Human anti-mouse antibodies Arch Pathol Lab Med. 2000 Jun;124(6):921-3. 3: Mouser VH, Abbadessa A, Levato R, Hennink WE, Vermonden T, Gawlitta D, Malda J. Development of a thermosensitive HAMA-containing bio-ink for the fabrication of composite cartilage repair constructs Biofabrication. 2017 Mar 23;9(1):015026. 4: Maier W, Buller R, Philipp M, Heuser I. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders J Affect Disord. 1988 Jan-Feb;14(1):61-8. 5: Imasaka KI, Tomita Y. Reply Ann Thorac Surg. 2018 Oct;106(4):1258-1259. 6: Boulestreau R, Lorthioir A, Persu A, Cremer A, Rubin S, Tharaux PL, Maier B, Mazighi M, Paques M, Bonnin S, Halimi JM, Gosse P. MALIGNANT HYPERTENSION HAMA COHORT: WHERE DO WE STAND IN 2021? J Hypertens. 2022 Jun 1;40(Suppl 1):e283. 7: Xia C, Chen P, Mei S, Ning L, Lei C, Wang J, Zhang J, Ma J, Fan S. Photo-crosslinked HAMA hydrogel with cordycepin encapsulated chitosan microspheres for osteoarthritis treatment Oncotarget. 2017 Jan 10;8(2):2835-2849. 8: Kasper S, Gastpar M, Müller WE, Volz HP, Möller HJ, Schläfke S, Dienel A. Lavender oil preparation Silexan is effective in generalized anxiety disorder–a randomized, double-blind comparison to placebo and paroxetine Int J Neuropsychopharmacol. 2014 Jun;17(6):859-69. 9: Imasaka KI, Tomita Y. Reply Ann Thorac Surg. 2018 Oct;106(4):1264-1265. 10: Matza LS, Morlock R, Sexton C, Malley K, Feltner D. Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder Int J Methods Psychiatr Res. 2010 Dec;19(4):223-32.
Interference